Co-Diagnostics, Inc.
做多
已更新

CODX Bullish Setup

443
CODX has now gained great bullish momentum for a breakout to the following targets. The Butterfly pattern is also indicating a new bullish trend to TP3 can take place.
注释
快照
交易结束:到达止损
注释
Second Quarter 2022 Financial Results:

Revenue of $5.0 million, down from $27.4 million during the prior year period, due primarily to lower demand of the Logix Smart™ COVID-19 Test

Gross profit of $4.1 million, representing 81.8% of consolidated revenue stemming from inefficiencies in lower sales volumes

Operating loss of $4.1 million compared to operating income of $11.8 million a year ago, due to lower sales volumes and continued investments into research and development

Net loss of $2.7 million, compared to a net income of $9.8 million in the prior-year second quarter, representing a loss of $0.08 per fully diluted share

Adjusted EBITDA loss of $2.3 million

免责声明

这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。